Neoantigen Vaccine Therapy Against H3.3-K27M Diffuse Intrinsic Pontine Glioma
Clinical trial NCT04749641 · COMPLETED
Trial details
- NCT number
- NCT04749641
- Sponsor
- Yang Zhang
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-08
- Primary completion
- 2024-10-14
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.